[{"edinetCode":"E00973","endDate":"2017\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":566.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":20562000.0,"sharesOwendPercent":0.6342,"outstandingShares":null,"numberOfSubsidiary":5.0,"bps":864.66,"equityRatio":0.75,"cashAndCashEquivalents":5464484000.0,"assets":36385034000.0,"currentAssets":20315173000.0,"fixedAsset":16069860000.0,"tangibleFixedAssets":11387729000.0,"intangibleFixedAssets":67615000.0,"investmentAndOtherAssets":4614515000.0,"liabilities":8799175000.0,"currentLiabilities":4706951000.0,"shorTermDept":1493600000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":4092224000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":2713200000.0,"netAsset":27585858000.0,"capitalStock":26689137000.0,"capital":9061866000.0,"capitalSurplus":10964676000.0,"accumulatedEarnings":8149279000.0,"treasuryStock":-1486686000.0,"valuationAndConversionAdjustments":616290000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":18085035000.0,"costOfSales":5731719000.0,"grossProfit":12353315000.0,"sgaExpenses":9991312000.0,"salaryAndBenefit":2143802000.0,"depreciationAndSGA":null,"RDExpenses":4071356000.0,"operatingIncome":2362003000.0,"nonOperatingIncome":236432000.0,"nonOperatingExpenses":64098000.0,"interestExpense":28989000.0,"ordinaryProfit":2534336000.0,"extraordinaryGain":20574000.0,"extraordinaryLoss":62122000.0,"incomeBeforeTax":2492788000.0,"incomeTaxes":629517000.0,"netIncome":1863270000.0,"netIncomeAttributableToOwnersOfTheParentCompany":1863170000.0,"comprehensiveIncome":1831347000.0,"eps":58.95,"dilutedEps":58.61,"dividendPerShare":null,"per":41.9,"roe":0.069,"cashFlowFromOperatingActivities":2651346000.0,"depreciationAndCashflowFromOperatingActivities":1447538000.0,"cashFlowFromInvestingActivities":-841403000.0,"cashFlowFromFinancialActivities":146302000.0,"changesInCashAndCashEquivalents":1941208000.0,"列1":"asr","submitDate":"2017\/6\/28","stockCode":4552,"accountingYear":"第42期（自　平成28年４月１日　至　平成29年３月31日）","accountingYearStart":"2016\/4\/1","accountingYearEnd":"2017\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00973","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":9061,"settlementDate":"2022\/3\/31","submitterName":"ＪＣＲファーマ株式会社","submitterNameEnglish":"JCR Pharmaceuticals Co.,Ltd.","submitterNameKana":"ジェーシーアールファーマカブシキガイシャ","location":"芦屋市春日町３番１９号","industory":"医薬品","corporateNumber":6140000000000.0},{"edinetCode":"E00973","endDate":"2018\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":568.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":20095000.0,"sharesOwendPercent":0.6512,"outstandingShares":null,"numberOfSubsidiary":6.0,"bps":877.86,"equityRatio":0.703,"cashAndCashEquivalents":4850000000.0,"assets":38398000000.0,"currentAssets":23327000000.0,"fixedAsset":15070000000.0,"tangibleFixedAssets":10853000000.0,"intangibleFixedAssets":112000000.0,"investmentAndOtherAssets":4104000000.0,"liabilities":10870000000.0,"currentLiabilities":7105000000.0,"shorTermDept":2893000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":3764000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":2500000000.0,"netAsset":27528000000.0,"capitalStock":26435000000.0,"capital":9061000000.0,"capitalSurplus":10947000000.0,"accumulatedEarnings":10469000000.0,"treasuryStock":-4042000000.0,"valuationAndConversionAdjustments":563000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":20594000000.0,"costOfSales":6128000000.0,"grossProfit":14465000000.0,"sgaExpenses":10681000000.0,"salaryAndBenefit":2234000000.0,"depreciationAndSGA":null,"RDExpenses":4211000000.0,"operatingIncome":3784000000.0,"nonOperatingIncome":105000000.0,"nonOperatingExpenses":46000000.0,"interestExpense":27000000.0,"ordinaryProfit":3843000000.0,"extraordinaryGain":77000000.0,"extraordinaryLoss":25000000.0,"incomeBeforeTax":3895000000.0,"incomeTaxes":825000000.0,"netIncome":3069000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":3070000000.0,"comprehensiveIncome":3016000000.0,"eps":98.73,"dilutedEps":98.11,"dividendPerShare":null,"per":61.5,"roe":0.113,"cashFlowFromOperatingActivities":3133000000.0,"depreciationAndCashflowFromOperatingActivities":1382000000.0,"cashFlowFromInvestingActivities":-1587000000.0,"cashFlowFromFinancialActivities":-2175000000.0,"changesInCashAndCashEquivalents":-614000000.0,"列1":"asr","submitDate":"2018\/6\/27","stockCode":4552,"accountingYear":"第43期（自　平成29年４月１日　至　平成30年３月31日）","accountingYearStart":"2017\/4\/1","accountingYearEnd":"2018\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00973","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":9061,"settlementDate":"2022\/3\/31","submitterName":"ＪＣＲファーマ株式会社","submitterNameEnglish":"JCR Pharmaceuticals Co.,Ltd.","submitterNameKana":"ジェーシーアールファーマカブシキガイシャ","location":"芦屋市春日町３番１９号","industory":"医薬品","corporateNumber":6140000000000.0},{"edinetCode":"E00973","endDate":"2019\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":632.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":20821000.0,"sharesOwendPercent":0.6739,"outstandingShares":null,"numberOfSubsidiary":6.0,"bps":982.14,"equityRatio":0.711,"cashAndCashEquivalents":8091000000.0,"assets":42516000000.0,"currentAssets":27368000000.0,"fixedAsset":15147000000.0,"tangibleFixedAssets":11061000000.0,"intangibleFixedAssets":110000000.0,"investmentAndOtherAssets":3975000000.0,"liabilities":11642000000.0,"currentLiabilities":8684000000.0,"shorTermDept":3630000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":2957000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":1850000000.0,"netAsset":30874000000.0,"capitalStock":29397000000.0,"capital":9061000000.0,"capitalSurplus":10922000000.0,"accumulatedEarnings":13350000000.0,"treasuryStock":-3937000000.0,"valuationAndConversionAdjustments":851000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":23160000000.0,"costOfSales":6567000000.0,"grossProfit":16592000000.0,"sgaExpenses":11625000000.0,"salaryAndBenefit":2399000000.0,"depreciationAndSGA":null,"RDExpenses":4354000000.0,"operatingIncome":4967000000.0,"nonOperatingIncome":148000000.0,"nonOperatingExpenses":47000000.0,"interestExpense":21000000.0,"ordinaryProfit":5068000000.0,"extraordinaryGain":82000000.0,"extraordinaryLoss":221000000.0,"incomeBeforeTax":4928000000.0,"incomeTaxes":1217000000.0,"netIncome":3710000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":3715000000.0,"comprehensiveIncome":4008000000.0,"eps":120.68,"dilutedEps":119.96,"dividendPerShare":null,"per":54.0,"roe":0.13,"cashFlowFromOperatingActivities":3905000000.0,"depreciationAndCashflowFromOperatingActivities":1343000000.0,"cashFlowFromInvestingActivities":240000000.0,"cashFlowFromFinancialActivities":-917000000.0,"changesInCashAndCashEquivalents":3241000000.0,"列1":"asr","submitDate":"2019\/6\/27","stockCode":4552,"accountingYear":"第44期（自　2018年４月１日　至　2019年３月31日）","accountingYearStart":"2018\/4\/1","accountingYearEnd":"2019\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00973","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":9061,"settlementDate":"2022\/3\/31","submitterName":"ＪＣＲファーマ株式会社","submitterNameEnglish":"JCR Pharmaceuticals Co.,Ltd.","submitterNameKana":"ジェーシーアールファーマカブシキガイシャ","location":"芦屋市春日町３番１９号","industory":"医薬品","corporateNumber":6140000000000.0},{"edinetCode":"E00973","endDate":"2019\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.72,"cashAndCashEquivalents":null,"assets":41658000000.0,"currentAssets":26664000000.0,"fixedAsset":14994000000.0,"tangibleFixedAssets":10820000000.0,"intangibleFixedAssets":255000000.0,"investmentAndOtherAssets":3917000000.0,"liabilities":11058000000.0,"currentLiabilities":8486000000.0,"shorTermDept":3980000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":2571000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":1500000000.0,"netAsset":30600000000.0,"capitalStock":29252000000.0,"capital":9061000000.0,"capitalSurplus":10913000000.0,"accumulatedEarnings":13195000000.0,"treasuryStock":-3918000000.0,"valuationAndConversionAdjustments":725000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":5155000000.0,"costOfSales":1607000000.0,"grossProfit":3548000000.0,"sgaExpenses":3087000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":461000000.0,"nonOperatingIncome":20000000.0,"nonOperatingExpenses":13000000.0,"interestExpense":5000000.0,"ordinaryProfit":467000000.0,"extraordinaryGain":9000000.0,"extraordinaryLoss":0.0,"incomeBeforeTax":476000000.0,"incomeTaxes":106000000.0,"netIncome":370000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":369000000.0,"comprehensiveIncome":243000000.0,"eps":12.0,"dilutedEps":11.93,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/8\/9","stockCode":4552,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00973","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":9061,"settlementDate":"2022\/3\/31","submitterName":"ＪＣＲファーマ株式会社","submitterNameEnglish":"JCR Pharmaceuticals Co.,Ltd.","submitterNameKana":"ジェーシーアールファーマカブシキガイシャ","location":"芦屋市春日町３番１９号","industory":"医薬品","corporateNumber":6140000000000.0},{"edinetCode":"E00973","endDate":"2019\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":20505000.0,"sharesOwendPercent":0.6631,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.669,"cashAndCashEquivalents":9968000000.0,"assets":45626000000.0,"currentAssets":27635000000.0,"fixedAsset":17990000000.0,"tangibleFixedAssets":13616000000.0,"intangibleFixedAssets":288000000.0,"investmentAndOtherAssets":4084000000.0,"liabilities":14350000000.0,"currentLiabilities":9686000000.0,"shorTermDept":4980000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":4663000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":3700000000.0,"netAsset":31276000000.0,"capitalStock":29829000000.0,"capital":9061000000.0,"capitalSurplus":10890000000.0,"accumulatedEarnings":13748000000.0,"treasuryStock":-3871000000.0,"valuationAndConversionAdjustments":675000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":11236000000.0,"costOfSales":3173000000.0,"grossProfit":8063000000.0,"sgaExpenses":7064000000.0,"salaryAndBenefit":1002000000.0,"depreciationAndSGA":null,"RDExpenses":3255000000.0,"operatingIncome":998000000.0,"nonOperatingIncome":28000000.0,"nonOperatingExpenses":46000000.0,"interestExpense":10000000.0,"ordinaryProfit":981000000.0,"extraordinaryGain":118000000.0,"extraordinaryLoss":2000000.0,"incomeBeforeTax":1098000000.0,"incomeTaxes":173000000.0,"netIncome":924000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":922000000.0,"comprehensiveIncome":747000000.0,"eps":29.95,"dilutedEps":29.77,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":2949000000.0,"depreciationAndCashflowFromOperatingActivities":658000000.0,"cashFlowFromInvestingActivities":-3612000000.0,"cashFlowFromFinancialActivities":2595000000.0,"changesInCashAndCashEquivalents":1876000000.0,"列1":"q2r","submitDate":"2019\/11\/14","stockCode":4552,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00973","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":9061,"settlementDate":"2022\/3\/31","submitterName":"ＪＣＲファーマ株式会社","submitterNameEnglish":"JCR Pharmaceuticals Co.,Ltd.","submitterNameKana":"ジェーシーアールファーマカブシキガイシャ","location":"芦屋市春日町３番１９号","industory":"医薬品","corporateNumber":6140000000000.0},{"edinetCode":"E00973","endDate":"2019\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.679,"cashAndCashEquivalents":null,"assets":45693000000.0,"currentAssets":27246000000.0,"fixedAsset":18446000000.0,"tangibleFixedAssets":13880000000.0,"intangibleFixedAssets":274000000.0,"investmentAndOtherAssets":4291000000.0,"liabilities":13914000000.0,"currentLiabilities":9239000000.0,"shorTermDept":4980000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":4674000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":3700000000.0,"netAsset":31779000000.0,"capitalStock":30250000000.0,"capital":9061000000.0,"capitalSurplus":10890000000.0,"accumulatedEarnings":14167000000.0,"treasuryStock":-3869000000.0,"valuationAndConversionAdjustments":755000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":18077000000.0,"costOfSales":5889000000.0,"grossProfit":12187000000.0,"sgaExpenses":10035000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":2152000000.0,"nonOperatingIncome":68000000.0,"nonOperatingExpenses":49000000.0,"interestExpense":16000000.0,"ordinaryProfit":2171000000.0,"extraordinaryGain":123000000.0,"extraordinaryLoss":2000000.0,"incomeBeforeTax":2292000000.0,"incomeTaxes":483000000.0,"netIncome":1809000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":1805000000.0,"comprehensiveIncome":1707000000.0,"eps":58.6,"dilutedEps":58.24,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2020\/2\/14","stockCode":4552,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00973","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":9061,"settlementDate":"2022\/3\/31","submitterName":"ＪＣＲファーマ株式会社","submitterNameEnglish":"JCR Pharmaceuticals Co.,Ltd.","submitterNameKana":"ジェーシーアールファーマカブシキガイシャ","location":"芦屋市春日町３番１９号","industory":"医薬品","corporateNumber":6140000000000.0},{"edinetCode":"E00973","endDate":"2020\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":667.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":20709000.0,"sharesOwendPercent":0.6697,"outstandingShares":null,"numberOfSubsidiary":6.0,"bps":1031.69,"equityRatio":0.666,"cashAndCashEquivalents":10928000000.0,"assets":47775000000.0,"currentAssets":28342000000.0,"fixedAsset":19433000000.0,"tangibleFixedAssets":14875000000.0,"intangibleFixedAssets":263000000.0,"investmentAndOtherAssets":4294000000.0,"liabilities":15195000000.0,"currentLiabilities":10434000000.0,"shorTermDept":4880000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":4761000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":3800000000.0,"netAsset":32579000000.0,"capitalStock":31127000000.0,"capital":9061000000.0,"capitalSurplus":10891000000.0,"accumulatedEarnings":15039000000.0,"treasuryStock":-3865000000.0,"valuationAndConversionAdjustments":679000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":24781000000.0,"costOfSales":7901000000.0,"grossProfit":16880000000.0,"sgaExpenses":13635000000.0,"salaryAndBenefit":2300000000.0,"depreciationAndSGA":null,"RDExpenses":5997000000.0,"operatingIncome":3244000000.0,"nonOperatingIncome":81000000.0,"nonOperatingExpenses":32000000.0,"interestExpense":22000000.0,"ordinaryProfit":3293000000.0,"extraordinaryGain":131000000.0,"extraordinaryLoss":2000000.0,"incomeBeforeTax":3422000000.0,"incomeTaxes":742000000.0,"netIncome":2679000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":2678000000.0,"comprehensiveIncome":2504000000.0,"eps":86.89,"dilutedEps":86.36,"dividendPerShare":null,"per":108.4,"roe":0.086,"cashFlowFromOperatingActivities":4927000000.0,"depreciationAndCashflowFromOperatingActivities":1434000000.0,"cashFlowFromInvestingActivities":-4161000000.0,"cashFlowFromFinancialActivities":2048000000.0,"changesInCashAndCashEquivalents":2836000000.0,"列1":"asr","submitDate":"2020\/6\/24","stockCode":4552,"accountingYear":"第45期（自　2019年４月１日　至　2020年３月31日）","accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00973","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":9061,"settlementDate":"2022\/3\/31","submitterName":"ＪＣＲファーマ株式会社","submitterNameEnglish":"JCR Pharmaceuticals Co.,Ltd.","submitterNameKana":"ジェーシーアールファーマカブシキガイシャ","location":"芦屋市春日町３番１９号","industory":"医薬品","corporateNumber":6140000000000.0},{"edinetCode":"E00973","endDate":"2020\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.569,"cashAndCashEquivalents":null,"assets":56396000000.0,"currentAssets":34331000000.0,"fixedAsset":22064000000.0,"tangibleFixedAssets":14682000000.0,"intangibleFixedAssets":3474000000.0,"investmentAndOtherAssets":3907000000.0,"liabilities":23535000000.0,"currentLiabilities":18874000000.0,"shorTermDept":13700000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":4661000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":3700000000.0,"netAsset":32860000000.0,"capitalStock":31409000000.0,"capital":9061000000.0,"capitalSurplus":10893000000.0,"accumulatedEarnings":15310000000.0,"treasuryStock":-3856000000.0,"valuationAndConversionAdjustments":678000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":5181000000.0,"costOfSales":1532000000.0,"grossProfit":3648000000.0,"sgaExpenses":2864000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":784000000.0,"nonOperatingIncome":92000000.0,"nonOperatingExpenses":14000000.0,"interestExpense":8000000.0,"ordinaryProfit":862000000.0,"extraordinaryGain":25000000.0,"extraordinaryLoss":3000000.0,"incomeBeforeTax":885000000.0,"incomeTaxes":115000000.0,"netIncome":770000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":767000000.0,"comprehensiveIncome":767000000.0,"eps":24.88,"dilutedEps":24.73,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/8\/13","stockCode":4552,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00973","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":9061,"settlementDate":"2022\/3\/31","submitterName":"ＪＣＲファーマ株式会社","submitterNameEnglish":"JCR Pharmaceuticals Co.,Ltd.","submitterNameKana":"ジェーシーアールファーマカブシキガイシャ","location":"芦屋市春日町３番１９号","industory":"医薬品","corporateNumber":6140000000000.0},{"edinetCode":"E00973","endDate":"2020\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":20211000.0,"sharesOwendPercent":0.6522,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.548,"cashAndCashEquivalents":19565000000.0,"assets":59708000000.0,"currentAssets":37504000000.0,"fixedAsset":22204000000.0,"tangibleFixedAssets":14400000000.0,"intangibleFixedAssets":3366000000.0,"investmentAndOtherAssets":4437000000.0,"liabilities":26236000000.0,"currentLiabilities":20755000000.0,"shorTermDept":13600000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":5480000000.0,"bonds":500000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":4000000000.0,"netAsset":33472000000.0,"capitalStock":32024000000.0,"capital":9061000000.0,"capitalSurplus":10928000000.0,"accumulatedEarnings":15737000000.0,"treasuryStock":-3703000000.0,"valuationAndConversionAdjustments":713000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":10951000000.0,"costOfSales":3513000000.0,"grossProfit":7438000000.0,"sgaExpenses":6130000000.0,"salaryAndBenefit":966000000.0,"depreciationAndSGA":null,"RDExpenses":2407000000.0,"operatingIncome":1307000000.0,"nonOperatingIncome":91000000.0,"nonOperatingExpenses":47000000.0,"interestExpense":18000000.0,"ordinaryProfit":1351000000.0,"extraordinaryGain":31000000.0,"extraordinaryLoss":1000000.0,"incomeBeforeTax":1381000000.0,"incomeTaxes":150000000.0,"netIncome":1231000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":1227000000.0,"comprehensiveIncome":1262000000.0,"eps":9.94,"dilutedEps":9.89,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":4232000000.0,"depreciationAndCashflowFromOperatingActivities":872000000.0,"cashFlowFromInvestingActivities":-4484000000.0,"cashFlowFromFinancialActivities":8867000000.0,"changesInCashAndCashEquivalents":8637000000.0,"列1":"q2r","submitDate":"2020\/11\/12","stockCode":4552,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00973","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":9061,"settlementDate":"2022\/3\/31","submitterName":"ＪＣＲファーマ株式会社","submitterNameEnglish":"JCR Pharmaceuticals Co.,Ltd.","submitterNameKana":"ジェーシーアールファーマカブシキガイシャ","location":"芦屋市春日町３番１９号","industory":"医薬品","corporateNumber":6140000000000.0},{"edinetCode":"E00973","endDate":"2020\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.514,"cashAndCashEquivalents":null,"assets":66511000000.0,"currentAssets":43757000000.0,"fixedAsset":22754000000.0,"tangibleFixedAssets":15168000000.0,"intangibleFixedAssets":3307000000.0,"investmentAndOtherAssets":4279000000.0,"liabilities":31609000000.0,"currentLiabilities":26210000000.0,"shorTermDept":13600000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":5398000000.0,"bonds":500000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":4000000000.0,"netAsset":34902000000.0,"capitalStock":33534000000.0,"capital":9061000000.0,"capitalSurplus":10941000000.0,"accumulatedEarnings":17218000000.0,"treasuryStock":-3686000000.0,"valuationAndConversionAdjustments":660000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":19424000000.0,"costOfSales":5811000000.0,"grossProfit":13612000000.0,"sgaExpenses":9659000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":3952000000.0,"nonOperatingIncome":159000000.0,"nonOperatingExpenses":65000000.0,"interestExpense":30000000.0,"ordinaryProfit":4045000000.0,"extraordinaryGain":127000000.0,"extraordinaryLoss":2000000.0,"incomeBeforeTax":4170000000.0,"incomeTaxes":899000000.0,"netIncome":3271000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":3264000000.0,"comprehensiveIncome":3245000000.0,"eps":26.44,"dilutedEps":26.3,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/2\/12","stockCode":4552,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00973","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":9061,"settlementDate":"2022\/3\/31","submitterName":"ＪＣＲファーマ株式会社","submitterNameEnglish":"JCR Pharmaceuticals Co.,Ltd.","submitterNameKana":"ジェーシーアールファーマカブシキガイシャ","location":"芦屋市春日町３番１９号","industory":"医薬品","corporateNumber":6140000000000.0},{"edinetCode":"E00973","endDate":"2021\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":732.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":78727000.0,"sharesOwendPercent":0.635,"outstandingShares":null,"numberOfSubsidiary":6.0,"bps":306.31,"equityRatio":0.513,"cashAndCashEquivalents":26260000000.0,"assets":73784000000.0,"currentAssets":48545000000.0,"fixedAsset":25238000000.0,"tangibleFixedAssets":17172000000.0,"intangibleFixedAssets":3232000000.0,"investmentAndOtherAssets":4833000000.0,"liabilities":35227000000.0,"currentLiabilities":29028000000.0,"shorTermDept":12850000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":6199000000.0,"bonds":500000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":4750000000.0,"netAsset":38557000000.0,"capitalStock":37222000000.0,"capital":9061000000.0,"capitalSurplus":10941000000.0,"accumulatedEarnings":20904000000.0,"treasuryStock":-3685000000.0,"valuationAndConversionAdjustments":641000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":30085000000.0,"costOfSales":7812000000.0,"grossProfit":22272000000.0,"sgaExpenses":14003000000.0,"salaryAndBenefit":2704000000.0,"depreciationAndSGA":null,"RDExpenses":5360000000.0,"operatingIncome":8269000000.0,"nonOperatingIncome":305000000.0,"nonOperatingExpenses":85000000.0,"interestExpense":42000000.0,"ordinaryProfit":8488000000.0,"extraordinaryGain":170000000.0,"extraordinaryLoss":5000000.0,"incomeBeforeTax":8653000000.0,"incomeTaxes":1764000000.0,"netIncome":6888000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":6892000000.0,"comprehensiveIncome":6841000000.0,"eps":55.81,"dilutedEps":55.53,"dividendPerShare":null,"per":64.2,"roe":0.198,"cashFlowFromOperatingActivities":10341000000.0,"depreciationAndCashflowFromOperatingActivities":1892000000.0,"cashFlowFromInvestingActivities":-3290000000.0,"cashFlowFromFinancialActivities":8304000000.0,"changesInCashAndCashEquivalents":15332000000.0,"列1":"asr","submitDate":"2021\/6\/23","stockCode":4552,"accountingYear":"第46期（自　2020年４月１日　至　2021年３月31日）","accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00973","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":9061,"settlementDate":"2022\/3\/31","submitterName":"ＪＣＲファーマ株式会社","submitterNameEnglish":"JCR Pharmaceuticals Co.,Ltd.","submitterNameKana":"ジェーシーアールファーマカブシキガイシャ","location":"芦屋市春日町３番１９号","industory":"医薬品","corporateNumber":6140000000000.0},{"edinetCode":"E00973","endDate":"2021\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.504,"cashAndCashEquivalents":null,"assets":76262000000.0,"currentAssets":51223000000.0,"fixedAsset":25039000000.0,"tangibleFixedAssets":17200000000.0,"intangibleFixedAssets":3181000000.0,"investmentAndOtherAssets":4657000000.0,"liabilities":37149000000.0,"currentLiabilities":30949000000.0,"shorTermDept":12850000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":6199000000.0,"bonds":500000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":4750000000.0,"netAsset":39113000000.0,"capitalStock":37834000000.0,"capital":9061000000.0,"capitalSurplus":10941000000.0,"accumulatedEarnings":21511000000.0,"treasuryStock":-3679000000.0,"valuationAndConversionAdjustments":569000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":9813000000.0,"costOfSales":2124000000.0,"grossProfit":7688000000.0,"sgaExpenses":4704000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":2984000000.0,"nonOperatingIncome":35000000.0,"nonOperatingExpenses":19000000.0,"interestExpense":10000000.0,"ordinaryProfit":3000000000.0,"extraordinaryGain":null,"extraordinaryLoss":1000000000.0,"incomeBeforeTax":1999000000.0,"incomeTaxes":463000000.0,"netIncome":1536000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":1532000000.0,"comprehensiveIncome":1476000000.0,"eps":12.4,"dilutedEps":12.34,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/8\/12","stockCode":4552,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00973","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":9061,"settlementDate":"2022\/3\/31","submitterName":"ＪＣＲファーマ株式会社","submitterNameEnglish":"JCR Pharmaceuticals Co.,Ltd.","submitterNameKana":"ジェーシーアールファーマカブシキガイシャ","location":"芦屋市春日町３番１９号","industory":"医薬品","corporateNumber":6140000000000.0},{"edinetCode":"E00973","endDate":"2021\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":81064000.0,"sharesOwendPercent":0.6532,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.534,"cashAndCashEquivalents":20412000000.0,"assets":86619000000.0,"currentAssets":58422000000.0,"fixedAsset":28197000000.0,"tangibleFixedAssets":20515000000.0,"intangibleFixedAssets":3096000000.0,"investmentAndOtherAssets":4584000000.0,"liabilities":39610000000.0,"currentLiabilities":35586000000.0,"shorTermDept":15050000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":4024000000.0,"bonds":500000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":2550000000.0,"netAsset":47008000000.0,"capitalStock":45666000000.0,"capital":9061000000.0,"capitalSurplus":10994000000.0,"accumulatedEarnings":29213000000.0,"treasuryStock":-3603000000.0,"valuationAndConversionAdjustments":583000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":28383000000.0,"costOfSales":4485000000.0,"grossProfit":23898000000.0,"sgaExpenses":10258000000.0,"salaryAndBenefit":1096000000.0,"depreciationAndSGA":null,"RDExpenses":3520000000.0,"operatingIncome":13640000000.0,"nonOperatingIncome":132000000.0,"nonOperatingExpenses":41000000.0,"interestExpense":22000000.0,"ordinaryProfit":13731000000.0,"extraordinaryGain":0.0,"extraordinaryLoss":1002000000.0,"incomeBeforeTax":12729000000.0,"incomeTaxes":3490000000.0,"netIncome":9238000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":9234000000.0,"comprehensiveIncome":9192000000.0,"eps":74.66,"dilutedEps":74.36,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-4747000000.0,"depreciationAndCashflowFromOperatingActivities":922000000.0,"cashFlowFromInvestingActivities":-236000000.0,"cashFlowFromFinancialActivities":-930000000.0,"changesInCashAndCashEquivalents":-5848000000.0,"列1":"q2r","submitDate":"2021\/11\/12","stockCode":4552,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00973","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":9061,"settlementDate":"2022\/3\/31","submitterName":"ＪＣＲファーマ株式会社","submitterNameEnglish":"JCR Pharmaceuticals Co.,Ltd.","submitterNameKana":"ジェーシーアールファーマカブシキガイシャ","location":"芦屋市春日町３番１９号","industory":"医薬品","corporateNumber":6140000000000.0},{"edinetCode":"E00973","endDate":"2021\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.521,"cashAndCashEquivalents":null,"assets":93430000000.0,"currentAssets":65521000000.0,"fixedAsset":27909000000.0,"tangibleFixedAssets":20652000000.0,"intangibleFixedAssets":3006000000.0,"investmentAndOtherAssets":4250000000.0,"liabilities":43974000000.0,"currentLiabilities":39973000000.0,"shorTermDept":15050000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":4000000000.0,"bonds":500000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":2550000000.0,"netAsset":49456000000.0,"capitalStock":48113000000.0,"capital":9061000000.0,"capitalSurplus":10994000000.0,"accumulatedEarnings":31659000000.0,"treasuryStock":-3601000000.0,"valuationAndConversionAdjustments":580000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":40270000000.0,"costOfSales":6826000000.0,"grossProfit":33444000000.0,"sgaExpenses":15087000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":18356000000.0,"nonOperatingIncome":426000000.0,"nonOperatingExpenses":57000000.0,"interestExpense":33000000.0,"ordinaryProfit":18724000000.0,"extraordinaryGain":0.0,"extraordinaryLoss":1002000000.0,"incomeBeforeTax":17722000000.0,"incomeTaxes":4795000000.0,"netIncome":12926000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":12921000000.0,"comprehensiveIncome":12879000000.0,"eps":104.45,"dilutedEps":104.03,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2022\/2\/14","stockCode":4552,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00973","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":9061,"settlementDate":"2022\/3\/31","submitterName":"ＪＣＲファーマ株式会社","submitterNameEnglish":"JCR Pharmaceuticals Co.,Ltd.","submitterNameKana":"ジェーシーアールファーマカブシキガイシャ","location":"芦屋市春日町３番１９号","industory":"医薬品","corporateNumber":6140000000000.0}]